ABSTRACT
The NLRP3 inflammasome responds to microbes and danger signals by processing and activating proinflammatory cytokines, including interleukin 1ß (IL-1ß) and IL-18. We found here that activation of the NLRP3 inflammasome was restricted to interphase of the cell cycle by NEK7, a serine-threonine kinase previously linked to mitosis. Activation of the NLRP3 inflammasome required NEK7, which bound to the leucine-rich repeat domain of NLRP3 in a kinase-independent manner downstream of the induction of mitochondrial reactive oxygen species (ROS). This interaction was necessary for the formation of a complex containing NLRP3 and the adaptor ASC, oligomerization of ASC and activation of caspase-1. NEK7 promoted the NLRP3-dependent cellular inflammatory response to intraperitoneal challenge with monosodium urate and the development of experimental autoimmune encephalitis in mice. Our findings suggest that NEK7 serves as a cellular switch that enforces mutual exclusivity of the inflammasome response and cell division.
Subject(s)
Carrier Proteins/immunology , Macrophages/immunology , Mitosis/immunology , Protein Serine-Threonine Kinases/immunology , Animals , Apoptosis , Apoptosis Regulatory Proteins , CARD Signaling Adaptor Proteins , Carrier Proteins/genetics , Caspase 1 , Chromatography, Gel , Colony-Forming Units Assay , Cytokines , Cytoskeletal Proteins , Dendritic Cells , Encephalomyelitis, Autoimmune, Experimental/immunology , Female , Flow Cytometry , HEK293 Cells , Humans , Immunoprecipitation , In Vitro Techniques , Inflammasomes/genetics , Inflammasomes/immunology , Macrophages, Peritoneal/immunology , Male , Mice , Mice, Inbred C57BL , Mice, Knockout , Mitochondria/metabolism , Monocytes , NIMA-Related Kinases , NLR Family, Pyrin Domain-Containing 3 Protein , Protein Serine-Threonine Kinases/genetics , Reactive Oxygen Species , Spinal Cord/immunologyABSTRACT
T lymphocytes responding to microbial infection give rise to effector cells that mediate acute host defense and memory cells that provide long-lived immunity, but the fundamental question of when and how these cells arise remains unresolved. Here we combined single-cell gene-expression analyses with 'machine-learning' approaches to trace the transcriptional 'roadmap' of individual CD8(+) T lymphocytes throughout the course of an immune response in vivo. Gene-expression signatures predictive of eventual fates could be discerned as early as the first T lymphocyte division and may have been influenced by asymmetric partitioning of the receptor for interleukin 2 (IL-2Rα) during mitosis. Our findings emphasize the importance of single-cell analyses in understanding fate determination and provide new insights into the specification of divergent lymphocyte fates early during an immune response to microbial infection.
Subject(s)
Adaptive Immunity , CD8-Positive T-Lymphocytes/immunology , Gene Expression Profiling/methods , Infections/immunology , Infections/microbiology , Receptors, Interleukin-2/metabolism , Single-Cell Analysis/methods , T-Lymphocyte Subsets/immunology , Adoptive Transfer , Animals , CD8-Positive T-Lymphocytes/microbiology , CD8-Positive T-Lymphocytes/virology , Cell Differentiation/genetics , Cell Lineage/genetics , Computer Simulation , Listeria monocytogenes/genetics , Listeria monocytogenes/immunology , Lymphocyte Activation/genetics , Mice , Mice, Inbred C57BL , Mice, Transgenic , Mitosis/genetics , Mitosis/immunology , Ovalbumin/genetics , Ovalbumin/immunology , Receptors, Interleukin-2/genetics , T-Lymphocyte Subsets/microbiology , T-Lymphocyte Subsets/virology , Transcriptional Activation/immunologyABSTRACT
Human embryonic stem cells (hESCs) are self-renewing and pluripotent cells that originate from the inner cell mass of the blastocyst. Mitosis is fundamental to organism survival and reproduction and is responsible for the equal distribution of duplicated chromosomes into daughter cells. Mitotic dysfunction is associated with a wide variety of human diseases, not least cancer. hESCs have a unique cell cycle distribution, but it is unclear exactly how the mitotic activity of hESCs is related to their proliferation and differentiation. Here, we established a cell line of hESCs stably expressing GFP-α-tubulin and mCherry-H2B by lentiviral infection to analyze and visualize mitosis in detail. During metaphase, the mitotic spindle was smaller and wider and contained a greater proportion of astral microtubules than normal cells. In addition, spindle microtubules were more stable, and chromosome alignment was faster in hESCs than in somatic cells. We also found that the spindle assembly checkpoint was functional in hESCs. These findings thus reveal a specialized mitotic behavior of hESCs.
Subject(s)
Human Embryonic Stem Cells/immunology , Mitosis/immunology , HeLa Cells , HumansABSTRACT
Carcinogenesis is characterized by abnormal regulation of cell growth and cell death. IK is a novel cell mitosis regulator that may contribute to carcinogenesis. Previous studies showed that the loss of IK expression resulted in cell mitotic arrest and even cell death. Besides, IK can also inhibit the interferon gamma (IFN-γ)-induced expression of human leukocyte antigen (HLA) class II antigen, which is associated with tumour immune microenvironment. To gain insight into the current research progress regarding IK, we conducted a review and searched the limited literature on IK using PubMed or Web of Science. In this review, we discussed the possible biological functions and mechanisms of IK in cancer and its immune microenvironment. Future perspectives of IK were also mentioned to explore its clinical significance.
Subject(s)
Carcinogenesis/immunology , Cytokines/immunology , Mitosis/immunology , Humans , Tumor Microenvironment/immunologyABSTRACT
The purpose of this review is to explore immune-mediated mechanisms of stress surveillance in cancer, with particular emphasis on the idea that all cancers have classical hallmarks (Hanahan and Weinberg in Cell 100:57-70, 67; Cell 144:646-674, 68) that could be interrelated. We postulate that hallmarks of cancer associated with cellular stress pathways (Luo et al. in Cell 136:823-837, 101) including oxidative stress, proteotoxic stress, mitotic stress, DNA damage, and metabolic stress could define and modulate the inflammatory component of cancer. As such, the overarching goal of this review is to define the types of cellular stress that cancer cells undergo, and then to explore mechanisms by which immune cells recognize, respond to, and are affected by each stress response.
Subject(s)
DNA Damage/immunology , Endoplasmic Reticulum Stress/immunology , Immunologic Surveillance/immunology , Neoplasms/immunology , Oxidative Stress/immunology , Animals , Humans , Mitosis/immunology , Models, Immunological , Neoplasms/genetics , Neoplasms/metabolism , Signal Transduction/immunologyABSTRACT
BACKGROUND: Mosquitoes respond to infection by mounting immune responses. The primary regulators of these immune responses are cells called hemocytes, which kill pathogens via phagocytosis and via the production of soluble antimicrobial factors. Mosquito hemocytes are circulated throughout the hemocoel (body cavity) by the swift flow of hemolymph (blood), and data show that some hemocytes also exist as sessile cells that are attached to tissues. The purpose of this study was to create a quantitative physical map of hemocyte distribution in the mosquito, Anopheles gambiae, and to describe the cellular immune response in an organismal context. RESULTS: Using correlative imaging methods we found that the number of hemocytes in a mosquito decreases with age, but that regardless of age, approximately 75% of the hemocytes occur in circulation and 25% occur as sessile cells. Infection induces an increase in the number of hemocytes, and tubulin and nuclear staining showed that this increase is primarily due to mitosis and, more specifically, autonomous cell division, by circulating granulocytes. The majority of sessile hemocytes are present on the abdominal wall, although significant numbers of hemocytes are also present in the thorax, head, and several of the appendages. Within the abdominal wall, the areas of highest hemocyte density are the periostial regions (regions surrounding the valves of the heart, or ostia), which are ideal locations for pathogen capture as these are areas of high hemolymph flow. CONCLUSIONS: These data describe the spatial and temporal distribution of mosquito hemocytes, and map the cellular response to infection throughout the hemocoel.
Subject(s)
Anopheles/immunology , Anopheles/microbiology , Escherichia coli/physiology , Hemocytes/microbiology , Hemocytes/pathology , Lymphocytes/cytology , Mitosis/immunology , Spatio-Temporal Analysis , Aging/immunology , Animals , Anopheles/cytology , Anopheles/growth & development , Carbocyanines/metabolism , Cell Adhesion , Cell Count , Cytoskeleton/metabolism , Epidermal Cells , Escherichia coli Infections/immunology , Escherichia coli Infections/microbiology , Flight, Animal , Hemocytes/immunology , Immunity , Muscles/cytology , Organ Specificity , Phagocytosis , SwimmingABSTRACT
Common wheat is an allohexaploid species originating from a naturally occurring inter-specific cross between tetraploid wheat and the diploid wild wheat Aegilops tauschii Coss. Artificial allopolyploidization can produce synthetic hexaploid wheat. However, synthetic triploid hybrids show four types of hybrid growth abnormalities: type II and III hybrid necrosis, hybrid chlorosis, and severe growth abortion. Of these hybrid abnormalities, type II necrosis is induced by low temperature. Under low temperature, elongation of stems and expansion of new leaves is repressed in type II necrosis lines, which later exhibit necrotic symptoms. Here, we characterize type II necrosis in detail. Comparative transcriptome analysis showed that a number of defense-related genes were highly up-regulated in seedling leaves that showed type II necrosis. Transmission electron microscopy revealed extensive cell death in the leaves under low-temperature conditions, accompanied by abundant generation of reactive oxygen species. In addition, down-regulation of cell cycle-related genes was observed in shoot apices of type II necrosis lines under low-temperature conditions. Quantitative RT-PCR and in situ hybridization showed repression of accumulation of histone H4 transcripts in the shoot apical meristem of type II necrosis lines. These results strongly suggest that an autoimmune response-like reaction and repression of cell division in the shoot apical meristem are associated with the abnormal growth phenotype in type II necrosis lines.
Subject(s)
Autoimmunity/genetics , Mitosis/genetics , Poaceae/physiology , Transcriptome , Triticum/physiology , Cell Death , Chromosome Mapping , Cold Temperature , Down-Regulation , Gene Expression Regulation, Plant , Genome, Plant/genetics , Histones/genetics , Hybridization, Genetic/physiology , Meristem/genetics , Meristem/growth & development , Meristem/physiology , Meristem/ultrastructure , Mitosis/immunology , Necrosis/genetics , Phenotype , Plant Leaves/genetics , Plant Leaves/growth & development , Plant Leaves/physiology , Plant Leaves/ultrastructure , Plant Proteins/genetics , Plant Proteins/metabolism , Plant Shoots/genetics , Plant Shoots/growth & development , Plant Shoots/physiology , Plant Shoots/ultrastructure , Poaceae/genetics , Poaceae/ultrastructure , Polyploidy , RNA, Messenger/genetics , RNA, Plant/genetics , Reactive Oxygen Species/metabolism , Triticum/genetics , Triticum/ultrastructureABSTRACT
Recently, great advancements have been made towards understanding the mechanisms underlying dermatomyositis (DM). Many novel autoantibodies, such as anti-MDA5, anti-TIF1γ, anti-NXP2, and anti-SAE, have been reported to be involved in DM. DM is now classified based on these myositis-specific autoantibodies. Anti-TIF1γ antibodies are closely associated with juvenile DM and adult cancer-associated DM. Anti-TIF1γ antibody-positive DM tends to present severe cutaneous manifestations, mild myositis, and dysphagia. TIF1γ (also known as TRIM33) plays a role in transcriptional elongation, DNA repair, differentiation of cells, embryonic development, and mitosis. Moreover, TIF1γ has been shown to suppress various tumors via the TGF-ß/Smad and the Wnt/ß-Catenin signaling pathways. In this review, we explore the relationship between TIF1γ, cancer, and DM. We also discuss the pathogenesis of anti-TIF1γ antibody-positive DM.
Subject(s)
Autoantibodies , Dermatomyositis/immunology , Nuclear Proteins/immunology , Transcription Factors/immunology , DNA Repair/immunology , Embryonic Development/immunology , Humans , Mitosis/immunology , Transcription Elongation, Genetic/immunology , Transcription Factors/physiology , Transforming Growth Factor beta/metabolism , Wnt Signaling Pathway/immunologyABSTRACT
The purpose of this research is to identify and characterize deleterious genetic variants in the co-stimulatory ligand B7-1, also known as the human cluster of differentiation CD80 marker. The B7-1 ligand and the major histocompatibility complex class II (MHC II) molecules are the main determinants that provide B-cells the required competency to act as antigen presenting cells. For this, participation of both MHC class II molecules and CD80 is required. The interaction of the CD80 ligand with CD28 on the surface 7 of TH cells plays a key role in the activation of TH cells and progression of B cells through the S phase, hence, leading to their proliferation in mitosis. A set of 2313 genetic variants in the B7-1 ligand have been mapped and retrieved from dbSNP database. Subsequently, 150 non-synonymous single nucleotide polymorphisms (nsSNPs) were mapped and subjected to the sequence and structural homology based predictions, which were further analyzed for protein stability and the disease phenotypes. Finally, we identified 7 potentially damaging nsSNPs in the B7-1 ligand that may affect its interaction with the cognitive receptor CD28, hence, may also interfere with TH cell activation and B cell proliferation. We propose that subsequent experimental analyses (stability, expression and interactions) on these proteins can provide a deep understanding about the effect of these variants on the structure and function of CD80.
Subject(s)
B-Lymphocytes/immunology , B7-1 Antigen/genetics , CD28 Antigens/metabolism , Lymphocyte Activation/genetics , T-Lymphocytes, Helper-Inducer/immunology , Adaptive Immunity/genetics , B7-1 Antigen/metabolism , Cell Proliferation/genetics , Computational Biology , Datasets as Topic , Humans , Mitosis/immunology , Polymorphism, Single Nucleotide/immunology , T-Lymphocytes, Helper-Inducer/metabolismABSTRACT
INTRODUCTION: The clinical significance of common antinuclear antibody (ANA) patterns, such as nuclear homogenous and nuclear speckled patterns with their corresponding specific antibodies, has already been established. However, the clinical relevance of these uncommon ANA patterns have not been well elucidated and these patterns are therefore not reported by most clinical laboratories. We herein report some retrospective data analysis linking patients' clinical status to several uncommon ANA patterns. METHODS: We retrieved and assessed the patient records for ANA reports generated in our hospital over a period of two years. All testing had been performed using the gold standard Indirect Immunofluorescence Assay. RESULTS: Records of 1235 consecutive patients tested for ANA were reviewed. ANA was positive in 330 of these patients with 6.39% found to have uncommon nuclear, cytoplasmic or mitotic sub-patterns. The mitotic spindle (0.89%), cytoplasmic anti-mitochondrial antibodies (0.80%), followed by discrete nuclear dots-multiple (0.72%) were the dominating patterns, with a higher prevalence in females than in males. Systemic lupus erythematosus and rheumatoid arthritis were the two most common autoimmune disorders associated with mitotic spindle fibers and nuclear centromere and nuclear large/coarse speckled ANA patterns. CONCLUSION: The prevalence of these relatively uncommon ANA patterns was higher than expected. Further evaluation of these patterns along with their corresponding antibodies and their clinical utility must be encouraged. We trust this endeavour will provide diagnostic information in autoimmune and other disease conditions.
Subject(s)
Antibodies, Antinuclear/analysis , Autoimmune Diseases/diagnosis , Adult , Antibodies, Antinuclear/immunology , Arthritis, Rheumatoid/immunology , Autoimmune Diseases/immunology , Biomarkers/analysis , Female , Fluorescent Antibody Technique, Indirect/methods , Humans , India , Lupus Erythematosus, Systemic/immunology , Male , Mitochondria/immunology , Mitosis/immunology , Nuclear Proteins/immunology , Retrospective Studies , Spindle Apparatus/immunology , Tertiary Care CentersABSTRACT
Psoriasis is a chronic inflammatory skin disease that develops under the influence of the IL-23/T helper 17 cell axis and is characterized by intense inflammation and prominent epidermal hyperplasia. In this study, we demonstrate that galectin-8, a ß-galactosideâbinding lectin, is upregulated in the epidermis of human psoriatic skin lesions as well as in a mouse model of psoriasis induced by intradermal IL-23 injections and in IL-17Aâtreated keratinocytes. We show that keratinocyte proliferation is less prominent in galectin-8âknockout mice after intradermal IL-23 treatment than in wild-type mice. In addition, we show that galectin-8 levels in keratinocytes are positively correlated with the ability of the cells to proliferate and that transitioning from mitosis into G1 phase is delayed in galectin-8âknockout HaCaT cells after cell-cycle synchronization and release. We demonstrate by immunofluorescence staining and immunoblotting the presence of galectin-8 within the mitotic apparatus. We reveal by coimmunoprecipitation and mass spectrometry analysis that α-tubulin interacts with galectin-8 during mitosis. Finally, we show that in the absence of galectin-8, pericentrin compactness is lessened and mitotic microtubule length is shortened, as demonstrated by immunofluorescence staining. We conclude that galectin-8 is upregulated in psoriasis and contributes to the hyperproliferation of keratinocytes by maintaining centrosome integrity during mitosis through interacting with α-tubulin.
Subject(s)
Epidermis/pathology , Galectins/genetics , Interleukin-17/metabolism , Psoriasis/immunology , Animals , Cell Proliferation , Disease Models, Animal , Epidermis/immunology , Galectins/metabolism , Gene Knockout Techniques , HaCaT Cells , Humans , Interleukin-23/administration & dosage , Interleukin-23/immunology , Mice , Mice, Knockout , Mitosis/immunology , Psoriasis/pathology , Recombinant Proteins/administration & dosage , Recombinant Proteins/immunology , Tubulin/metabolism , Up-Regulation/immunologyABSTRACT
The tumour microenvironment is of critical importance in cancer development and progression and includes the surrounding stromal and immune cells, extracellular matrix, and the milieu of metabolites and signalling molecules in the intercellular space. To support sustained mitotic activity cancer cells must reconfigure their metabolic phenotype. Lactate is the major by-product of such metabolic alterations and consequently, accumulates in the tumour. Lactate actively contributes to immune evasion, a hallmark of cancer, by directly inhibiting immune cell cytotoxicity and proliferation. Furthermore, lactate can recruit and induce immunosuppressive cell types, such as regulatory T cells, tumour-associated macrophages, and myeloid-derived suppressor cells which further suppress anti-tumour immune responses. Given its roles in oncogenesis, measuring intratumoural and systemic lactate levels has shown promise as a both predictive and prognostic biomarker in several cancer types. The efficacies of many anti-cancer therapies are limited by an immunosuppressive TME in which lactate is a major contributor, therefore, targeting lactate metabolism is a priority. Developing inhibitors of key proteins in lactate metabolism such as GLUT1, hexokinase, LDH, MCT and HIF have shown promise in preclinical studies, however there is a corresponding lack of success in human trials so far. This may be explained by a weakness of preclinical models that fail to reproduce the complexities of metabolic interactions in natura. The future of these therapies may be as an adjunct to more conventional treatments.
Subject(s)
Antineoplastic Agents/therapeutic use , Carcinogenesis/drug effects , Glycolysis/genetics , Neoplasms/drug therapy , Glucose Transporter Type 1/antagonists & inhibitors , Glycolysis/drug effects , Hexokinase/antagonists & inhibitors , Humans , Immune Tolerance/genetics , Immune Tolerance/immunology , Immunity/drug effects , Immunity/immunology , Immunosuppression Therapy , L-Lactate Dehydrogenase/antagonists & inhibitors , Lactic Acid/immunology , Lactic Acid/metabolism , Mitosis/drug effects , Mitosis/immunology , Monocarboxylic Acid Transporters/antagonists & inhibitors , Neoplasms/genetics , Neoplasms/immunology , Neoplasms/metabolism , Signal Transduction/drug effects , T-Lymphocytes, Regulatory/drug effects , T-Lymphocytes, Regulatory/immunology , Tumor Microenvironment/drug effectsABSTRACT
To kill antigen-specific target cells (TCs), cytotoxic T lymphocytes (CTLs) reorganise their microtubule cytoskeleton to deliver lytic granules to the TCs. We used two drugs that stabilise microtubules, paclitaxel and peloruside, to determine how the stabilising microtubule network affects CTL function in vitro and in vivo. In vitro, neither paclitaxel nor peloruside inhibited antigen-specific killing, lytic granule delivery to the cell surface, nor interferon-gamma release by murine CTLs. In contrast, in an in vivo murine model of antigen-induced killing, a single dose of paclitaxel had a significant inhibitory effect on killing by CTLs. Furthermore, the inhibitory effect of paclitaxel was not caused by specific deletion of the effector CTL population in drug-treated mice. The findings reveal that microtubule-stabilising drug treatment can lead to immediate impairment of CTL function without affecting lytic granule release. The results also suggest that patients undergoing taxane anti-cancer therapy may be impaired in their ability to fight infection before the anti-mitotic effects of paclitaxel are apparent.
Subject(s)
Clonal Deletion/drug effects , Mitosis/drug effects , Models, Immunological , Paclitaxel/pharmacology , T-Lymphocytes, Cytotoxic/immunology , Tubulin Modulators/pharmacology , Animals , Antigens/immunology , Clonal Deletion/immunology , Dose-Response Relationship, Drug , Interferon-gamma/immunology , Mice , Mice, Transgenic , Microtubules/immunology , Mitosis/immunology , Secretory Vesicles/immunologyABSTRACT
Morphological, cytological, morphometric changes were studied in single lymphoid nodules and in grouped lymphoid nodules (Peyers patches) of small intestine in albino rats after the dehydration lasting 3, 6, and 10 days and correction by administration of sodium chloride isotonic solution. In was found that the dehydration resulted in the decrease of lymphoid nodule dimensions, changes in the cellular proportions, enlargement of reticular fiber loops in the nodule stroma. On days 6 and 10 of dehydration, the percentages of macrophages, lymphocytes, cells showing the mitotic figures, mast cells and plasma cells were significantly decreased by factor of 1,4-4, indicating a depression of immune reactions.
Subject(s)
Dehydration , Intestine, Small , Lymphocytes , Macrophages , Mitosis/immunology , Peyer's Patches , Animals , Dehydration/immunology , Dehydration/pathology , Intestine, Small/immunology , Intestine, Small/pathology , Isotonic Solutions/pharmacology , Lymphocytes/immunology , Lymphocytes/pathology , Macrophages/immunology , Macrophages/pathology , Male , Peyer's Patches/immunology , Peyer's Patches/pathology , Rats , Sodium Chloride/pharmacology , Time FactorsABSTRACT
Male factor infertility is a problem in today's society but many underlying causes are still unknown. The generation of a conditional Sertoli cell (SC)-specific connexin 43 (Cx43) knockout mouse line (SCCx43KO) has provided a translational model. Expression of the gap junction protein Cx43 between adjacent SCs as well as between SCs and germ cells (GCs) is known to be essential for the initiation and maintenance of spermatogenesis in different species and men. Adult SCCx43KO males show altered spermatogenesis and are infertile. Thus, the present study aims to identify molecular mechanisms leading to testicular alterations in prepubertal SCCx43KO mice. Transcriptome analysis of 8-, 10- and 12-day-old mice was performed by next-generation sequencing (NGS). Additionally, candidate genes were examined by qRT-PCR and immunohistochemistry. NGS revealed many significantly differentially expressed genes in the SCCx43KO mice. For example, GCspecific genes were mostly downregulated and found to be involved in meiosis and spermatogonial differentiation (e.g., Dmrtb1, Sohlh1). In contrast, SC-specific genes implicated in SC maturation and proliferation were mostly upregulated (e.g., Amh, Fshr). In conclusion, Cx43 in SCs appears to be required for normal progression of the first wave of spermatogenesis, especially for the mitosis-meiosis switch, and also for the regulation of prepubertal SC maturation.
Subject(s)
Connexin 43/metabolism , Meiosis/immunology , Mitosis/immunology , Sertoli Cells/metabolism , Animals , Cell Differentiation , Male , Mice , Mice, KnockoutABSTRACT
As one of the representatives of jawless vertebrates, lamprey is an important animal model for research on the evolution of adaptive immune system. Although it is widely accepted that the key characteristic of the immune response in jawed vertebrates is the functional cooperation between different immune effector cell lineages, whether immune cells of lamprey can communicate with each other is still unclear. Recently, mounting evidence has revealed the emerging role of exosomes in mediating intercellular communication. In this study, by means of ultrafiltration followed by size exclusion chromatography, exosomes are purified from conditioned growth medium of the primary supraneural myeloid body cells (SMB cells) in LPS-immunized and control Lampetra japonica (Japanese lamprey). The proteomic profiling and qualitative comparison are performed between protein components enriched in exosomes released by SMB cells under quiescent and activated conditions. Our results demonstrate that SMB cells can release exosomes with well-defined characteristics comparable to their mammalian counterparts on their size, morphology and protein markers, which supports exosomes are evolutionarily conserved between lamprey and other higher vertebrate species. In terms of comparison with exosomes released by quiescent SMB cells, activated SMB cell-derived exosomes contain more and significantly different protein components. The unique exosomal protein 'fingerprint' might reflect that exosomes from the SMB cells with different states of activation have distinguishing functional roles as well as targeting properties. Further bioinformatic analysis suggests that compared to quiescent exosomes, activated SMB cell-derived exosomes mainly participate in distinctive biological processes including activation of cellular component biogenesis and regulation of cell proliferation. Moreover, activated exosomes may function through the specific signaling pathways associated with the regulation of cell mitosis and immune response. Our results give valuable clues about the immunomodulatory functions of SMB cell-derived exosomes and provide the foundation for further investigation in the regulation mechanism of the adaptive immune response in lamprey.
Subject(s)
Adaptive Immunity/immunology , Exosomes/immunology , Lampreys/immunology , Myeloid Cells/immunology , Animals , Cell Communication/immunology , Cell Proliferation/physiology , Fish Proteins/immunology , Gene Expression Profiling/methods , Lymphocytes/immunology , Mitosis/immunology , Proteomics/methods , Signal Transduction/immunologyABSTRACT
The ankyrin repeat domain-55 (ANKRD55) gene contains intronic single nucleotide polymorphisms (SNPs) associated with risk to contract multiple sclerosis, rheumatoid arthritis or other autoimmune disorders. Risk alleles of these SNPs are associated with higher levels of ANKRD55 in CD4+ T cells. The biological function of ANKRD55 is unknown, but given that ankyrin repeat domains constitute one of the most common protein-protein interaction platforms in nature, it is likely to function in complex with other proteins. Thus, identification of its protein interactomes may provide clues. We identified ANKRD55 interactomes via recombinant overexpression in HEK293 or HeLa cells and mass spectrometry. One hundred forty-eight specifically interacting proteins were found in total protein extracts and 22 in extracts of sucrose gradient-purified nuclei. Bioinformatic analysis suggested that the ANKRD55-protein partners from total protein extracts were related to nucleotide and ATP binding, enriched in nuclear transport terms and associated with cell cycle and RNA, lipid and amino acid metabolism. The enrichment analysis of the ANKRD55-protein partners from nuclear extracts is related to sumoylation, RNA binding, processes associated with cell cycle, RNA transport, nucleotide and ATP binding. The interaction between overexpressed ANKRD55 isoform 001 and endogenous RPS3, the cohesins SMC1A and SMC3, CLTC, PRKDC, VIM, ß-tubulin isoforms, and 14-3-3 isoforms were validated by western blot, reverse immunoprecipitaton and/or confocal microscopy. We also identified three phosphorylation sites in ANKRD55, with S436 exhibiting the highest score as likely 14-3-3 binding phosphosite. Our study suggests that ANKRD55 may exert function(s) in the formation or architecture of multiple protein complexes, and is regulated by (de)phosphorylation reactions. Based on interactome and subcellular localization analysis, ANKRD55 is likely transported into the nucleus by the classical nuclear import pathway and is involved in mitosis, probably via effects associated with mitotic spindle dynamics.
Subject(s)
Carrier Proteins/immunology , Cell Nucleus/metabolism , Mitosis/immunology , Protein Interaction Maps/immunology , Active Transport, Cell Nucleus/genetics , Active Transport, Cell Nucleus/immunology , Autoimmune Diseases/genetics , Autoimmune Diseases/immunology , Carrier Proteins/genetics , Cell Nucleus/genetics , HEK293 Cells , HeLa Cells , Humans , Mitosis/genetics , Polymorphism, Single NucleotideABSTRACT
OBJECTIVES: Little is known about the transcriptional events underlying megakaryocytic (Mk) differentiation. We sought to identify genes and pathways previously unassociated with megakaryopoiesis and to evaluate the CHRF-288-11 (CHRF) megakaryoblastic cell line as a model system for investigating megakaryopoiesis. METHODS: Using DNA microarrays, Q-RT-PCR, and protein-level assays, we compared the dynamic gene expression pattern of phorbol ester-induced differentiation of CHRF cells to cytokine-induced Mk differentiation of human mobilized peripheral blood CD34(+) cells. RESULTS: Transcriptional patterns of well-known Mk genes were similar between the two systems. CHRF cells constitutively express some early Mk genes including GATA-1. Expression patterns of apoptosis-related genes suggested that increased p53 activity is involved in Mk apoptosis, and this was confirmed by p53-DNA-binding activity data and flow-cytometric analysis of the p53 target gene BBC3. Certain Rho and G-protein-coupled-receptor signaling pathway components were upregulated, including genes not previously associated with Mk cells. Ontological analysis revealed upregulation of defense-response genes, including both known and candidate platelet-derived contributors to inflammation. Upregulation of interferon-responsive genes occurred in the cell line, but not in the primary cells, likely due to a known genetic mutation in the JAK2/STAT5 signaling pathway. CONCLUSIONS: This analysis of megakaryopoiesis, which integrates dynamic gene expression data with protein abundance and activity assays, has identified a number of genes and pathways that may help govern megakaryopoiesis. Furthermore, the transcriptional data support the hypothesis that CHRF cells resemble an early Mk phenotype and, with certain limitations, exhibit genuine transcriptional features of Mk differentiation upon treatment with phorbol esters.
Subject(s)
Cell Differentiation/immunology , Genome , Megakaryocytes/immunology , Transcription, Genetic/genetics , Apoptosis/genetics , Cell Cycle/immunology , Cell Differentiation/drug effects , Cell Differentiation/genetics , Cell Line , Cell Lineage/genetics , Cells, Cultured , Cluster Analysis , Flow Cytometry/methods , GTPase-Activating Proteins/immunology , Gene Expression Profiling , Humans , Megakaryocytes/drug effects , Mitosis/immunology , Oligonucleotide Array Sequence Analysis/methods , Phenotype , Receptors, G-Protein-Coupled/immunology , Reverse Transcriptase Polymerase Chain Reaction/methods , Signal Transduction/immunology , Tetradecanoylphorbol Acetate/pharmacology , Tumor Suppressor Protein p53/immunologyABSTRACT
Oestrogen receptor beta (ERß) and epidermal growth factor receptor (EGFR) pathway can synergistically promote the proliferation, invasion, and metastasis of non-small-cell lung cancer (NSCLC) cells. ERß has five subtypes, and the selective splicing of exon 8 in ERß5 transcription translational phase makes its biological function different from other subtypes. The following study investigates whether ERß5 interacts with EGFR pathway in lung cancer. Briefly, we found that the overexpression of ERß5 and EGFR is associated with poor prognosis and decreased overall survival in NSCLC patients. Furthermore, the effects of ERß5 and EGFR on cell biological behaviour were investigated in vitro. These results indicated that the combination of ERß5 and EGF induces cell proliferation and invasion, while the combination of ERß5 and Gefitinib (EGFR inhibitors, Gef) induces cell apoptosis and promotes cell mitosis in A549 cell line. In addition, the combination of ERß5 and EGF increases the expression of ERß5, EGFR, and p-ERK1/2 in lung cancer cells. To sum up, the obtained results suggest that ERß5 and EGFR synergistically promote the progression of lung cancer by activating MEK/ERK signalling pathway, which provides a theoretical basis for more accurate combined targeted therapy.